The Motley Fool
Positive
6/23 8:30 PM
2 High-Yield Dividend Stocks to Buy and Hold for a Decade
These healthcare leaders have encountered challenges in recent years. However, they are slowly improving their businesses, partly through innovation.
Zacks Investment Research
Positive
6/22 2:31 PM
Is It Worth Investing in Medtronic (MDT) Based on Wall Street's Bullish Views?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Barrons
Positive
6/18 11:01 AM
This Undervalued Medical-Devices Stock Is Poised for a Rebound
Medtronic offers high growth potential in addition to discounted valuation.
The Motley Fool
Positive
6/17 3:00 PM
Worried About a Market Crash? These 3 Dividend Stocks Could Help Reduce Your Risk
These stocks pay between 2.9% and 5.2% in dividends. Their low beta values indicate that they don't follow the market too closely.
Zacks Investment Research
Neutral
6/16 3:26 PM
Is the Options Market Predicting a Spike in Medtronic Stock?
Investors need to pay close attention to MDT stock based on the movements in the options market lately.
The Motley Fool
Positive
6/16 10:15 AM
3 Dividend Stocks to Hold for the Long Haul
These three healthcare leaders are slowly overcoming recent obstacles. They have strong dividend track records and the means to maintain healthy dividend growth.
Benzinga
Negative
6/15 3:29 PM
The Hormuz Reopening Trade: These 20 Large-Cap Stocks Still Haven't Caught Up To Pre-War Levels
Wall Street rallied toward record highs Monday as President Donald Trump declared the Strait of Hormuz reopened and oil prices plunged, yet a cluster of the market's biggest names are still trading well below their pre-war levels.
24/7 Wall Street
Positive
6/14 2:57 PM
Got $2,500? 1 Unstoppable Medical Juggernaut to Buy Hand Over Fist and Hold for the Next 20 Years
For an investor in their 50s or 60s who is finished chasing trends, Medtronic (NYSE:MDT | MDT Price Prediction) is a stock worth owning for decades because it pairs inelastic demand for medical devices with a 49th consecutive year of dividend increases.
Seeking Alpha
Positive
6/13 7:30 AM
Dividend Announcements: May 30-June 5, 2026
In this article series, I summarize dividend announcements of the past week. Six stocks in my database announced dividend increases, including one stock I own, and one declared a special dividend. W. R. Berkley stands out with an 11.1% dividend increase, a 50¢ special dividend, and the highest quality score this week. Medtronic offers the most value, trading 9% below fair value, but its dividend growth is modest at 1.4%.
PRNewsWire
Neutral
6/12 3:00 PM
Medtronic completes acquisition of Scientia Vascular, seamlessly integrating access and therapeutic portfolios for neurovascular care
Acquisition delivers simplicity and access, supporting physicians across the full procedural workflow GALWAY, Ireland, June 12, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has completed its acquisition of Scientia Vascular, a privately-held medical device company in Salt Lake City. The acquisition is valued at $550 million, subject to customary adjustments, with potential undisclosed earn-out and milestone payments post-acquisition.
52W Range
$73.31 - $106.33
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
